- Home
- CHRW vs EXAS Comparison
CHRW vs EXAS Comparison
Compare CHRW & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- EXAS
- Stock Information
- Founded
- CHRW 1905
- EXAS 1995
- Country
- CHRW United States
- EXAS United States
- Employees
- CHRW N/A
- EXAS N/A
- Industry
- CHRW Oil Refining/Marketing
- EXAS Medical Specialities
- Sector
- CHRW Consumer Discretionary
- EXAS Health Care
- Exchange
- CHRW Nasdaq
- EXAS Nasdaq
- Market Cap
- CHRW 12.9B
- EXAS 10.5B
- IPO Year
- CHRW 1997
- EXAS N/A
- Fundamental
- Price
- CHRW $98.83
- EXAS $54.75
- Analyst Decision
- CHRW Buy
- EXAS Strong Buy
- Analyst Count
- CHRW 18
- EXAS 17
- Target Price
- CHRW $120.69
- EXAS $72.63
- AVG Volume (30 Days)
- CHRW 1.2M
- EXAS 2.4M
- Earning Date
- CHRW 01-29-2025
- EXAS 02-19-2025
- Dividend Yield
- CHRW 2.50%
- EXAS N/A
- EPS Growth
- CHRW 41.91
- EXAS N/A
- EPS
- CHRW 3.86
- EXAS N/A
- Revenue
- CHRW $17,724,956,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- CHRW $5.73
- EXAS $11.89
- Revenue Next Year
- CHRW $4.85
- EXAS $11.48
- P/E Ratio
- CHRW $25.60
- EXAS N/A
- Revenue Growth
- CHRW 0.73
- EXAS 11.91
- 52 Week Low
- CHRW $65.00
- EXAS $40.62
- 52 Week High
- CHRW $114.82
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- CHRW 35.40
- EXAS 45.03
- Support Level
- CHRW $96.73
- EXAS $53.99
- Resistance Level
- CHRW $110.25
- EXAS $57.23
- Average True Range (ATR)
- CHRW 2.68
- EXAS 2.35
- MACD
- CHRW -0.74
- EXAS 0.23
- Stochastic Oscillator
- CHRW 15.53
- EXAS 66.40
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.